ARWR vs. PODD
Compare and contrast key facts about Arrowhead Pharmaceuticals, Inc. (ARWR) and Insulet Corporation (PODD).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ARWR or PODD.
Key characteristics
ARWR | PODD | |
---|---|---|
YTD Return | -6.21% | -22.03% |
1Y Return | 18.30% | -45.65% |
3Y Return (Ann) | -23.11% | -14.11% |
5Y Return (Ann) | 9.40% | 12.24% |
10Y Return (Ann) | 6.29% | 13.65% |
Sharpe Ratio | 0.29 | -1.12 |
Daily Std Dev | 63.14% | 41.30% |
Max Drawdown | -99.96% | -90.28% |
Current Drawdown | -99.02% | -48.77% |
Fundamentals
ARWR | PODD | |
---|---|---|
Market Cap | $3.37B | $11.49B |
EPS | -$2.77 | $2.94 |
PEG Ratio | -1.32 | 2.95 |
Revenue (TTM) | $181.74M | $1.70B |
Gross Profit (TTM) | $240.74M | $805.60M |
EBITDA (TTM) | -$285.35M | $308.60M |
Correlation
The correlation between ARWR and PODD is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ARWR vs. PODD - Performance Comparison
In the year-to-date period, ARWR achieves a -6.21% return, which is significantly higher than PODD's -22.03% return. Over the past 10 years, ARWR has underperformed PODD with an annualized return of 6.29%, while PODD has yielded a comparatively higher 13.65% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Risk-Adjusted Performance
ARWR vs. PODD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Arrowhead Pharmaceuticals, Inc. (ARWR) and Insulet Corporation (PODD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
---|---|---|---|---|---|
Arrowhead Pharmaceuticals, Inc. | 0.28 | ||||
Insulet Corporation | -1.12 |
Dividends
ARWR vs. PODD - Dividend Comparison
Neither ARWR nor PODD has paid dividends to shareholders.
Drawdowns
ARWR vs. PODD - Drawdown Comparison
The maximum ARWR drawdown since its inception was -99.96%, which is greater than PODD's maximum drawdown of -90.28%. The drawdown chart below compares losses from any high point along the way for ARWR and PODD
Volatility
ARWR vs. PODD - Volatility Comparison
Arrowhead Pharmaceuticals, Inc. (ARWR) has a higher volatility of 24.03% compared to Insulet Corporation (PODD) at 11.12%. This indicates that ARWR's price experiences larger fluctuations and is considered to be riskier than PODD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.